Tadokoro K - Search Results

1

Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group.

Takahashi K, Juji T, Miyamoto M, Uchida S, Akaza T, Tadokoro K, Shibata Y, Ino T, Hidano A. Takahashi K, et al. Among authors: tadokoro k. Lancet. 1994 Mar 19;343(8899):700-2. doi: 10.1016/s0140-6736(94)91580-6. Lancet. 1994. PMID: 7907679

2

Identification of HLA class II antigens as the targets of effector clones which may cause transfusion-associated graft-versus-host disease.

Nishimura M, Uchida S, Mitsunaga S, Yahagi Y, Nakajima K, Tadokoro K, Juji T. Nishimura M, et al. Among authors: tadokoro k. Transfus Med. 1997 Jun;7(2):89-94. doi: 10.1046/j.1365-3148.1997.d01-9.x. Transfus Med. 1997. PMID: 9195693

3

Differential effect of azidothymidine on resting and activated cells: potentiality of this drug for treatment of post-transfusion graft-versus-host disease.

Nishimura M, Hidaka N, Akaza T, Tadokoro K, Juji T. Nishimura M, et al. Among authors: tadokoro k. Res Commun Mol Pathol Pharmacol. 1998 May;100(2):131-8. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9667067

4

Immunosuppressive effects of chloroquine: potential effectiveness for treatment of post-transfusion graft-versus-host disease.

Nishimura M, Hidaka N, Akaza T, Tadokoro K, Juji T. Nishimura M, et al. Among authors: tadokoro k. Transfus Med. 1998 Sep;8(3):209-14. doi: 10.1046/j.1365-3148.1998.00160.x. Transfus Med. 1998. PMID: 9800293

5

Treatment of post transfusion graft-versus-host disease.

Juji T, Nishimura M, Tadokoro K. Juji T, et al. Among authors: tadokoro k. Vox Sang. 2000;78 Suppl 2:277-9. Vox Sang. 2000. PMID: 10938969

6

Brief report: polymorphic microsatellite markers for the diagnosis of graft-versus-host disease.

Wang L, Juji T, Tokunaga K, Takahashi K, Kuwata S, Uchida S, Tadokoro K, Takai K. Wang L, et al. Among authors: tadokoro k. N Engl J Med. 1994 Feb 10;330(6):398-401. doi: 10.1056/NEJM199402103300605. N Engl J Med. 1994. PMID: 8284005 Free article. No abstract available.

7

Evidence of involvement of cytotoxic antibodies directed against patients's HLA class II produced by transfused donor-derived B cells in post-transfusion graft-versus-host disease.

Nishimura M, Uchida S, Mitsunaga S, Tokunaga K, Tadokoro K, Juji T. Nishimura M, et al. Among authors: tadokoro k. Br J Haematol. 1996 Mar;92(4):1011-3. doi: 10.1046/j.1365-2141.1996.430973.x. Br J Haematol. 1996. PMID: 8616060

8

Characterization of T-cell clones derived from peripheral blood lymphocytes of a patient with transfusion-associated graft-versus-host disease: Fas-mediated killing by CD4+ and CD8+ cytotoxic T-cell clones and tumor necrosis factor beta production by CD4+ T-cell clones.

Nishimura M, Uchida S, Mitsunaga S, Yahagi Y, Nakajima K, Tadokoro K, Juji T. Nishimura M, et al. Among authors: tadokoro k. Blood. 1997 Feb 15;89(4):1440-5. Blood. 1997. PMID: 9028968 Free article.

9

Potential usefulness of protease inhibitor and chloroquine in the treatment of transfusion-associated graft-versus-host disease.

Nishimura M, Akaza T, Tadokoro K, Juji T. Nishimura M, et al. Among authors: tadokoro k. Transfusion. 1997 Jul;37(7):768-70. doi: 10.1046/j.1537-2995.1997.37797369456.x. Transfusion. 1997. PMID: 9225944 No abstract available.

10

[Possible involvement of donor-derived B cells in development of post-transfusion graft-versus-host disease].

Nishimura M, Akaza T, Tadokoro K, Juji T. Nishimura M, et al. Among authors: tadokoro k. Nihon Rinsho. 1997 Sep;55(9):2246-51. Nihon Rinsho. 1997. PMID: 9301284 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page